TABLE 1.
Antituberculous drug | Concn (μg/ml) | Susceptibilitya of BCG strain:
|
||||
---|---|---|---|---|---|---|
BCG-Bulgaria (SL 222 Sofia) | BCG-Connaught | BCG-Denmark (SSI 1331) | BCG-Japan (Tokyo 172) | BCG-Medac (RIVM from 1173-P2) | ||
First-line antituberculous drugs | ||||||
Isoniazid | 0.1 | S | R | R | S | S |
Isoniazid | 0.4 | S | S | S | S | S |
Rifampin | 1.0 | S | S | S | S | S |
Rifabutin | 0.5 | S | S | S | S | S |
Pyrazinamide | 100.0 | R | R | R | R | R |
Ethambutol | 5.0 | S | S | S | S | S |
Second-line antituberculous drugs | ||||||
Ethionamide | 5.0 | S | R | R | S | S |
Ciprofloxacin | 1.0 | S | S | S | S | S |
Ofloxacin | 1.0 | S | S | S | S | S |
Streptomycin | 1.0 | S | S | S | S | S |
Amikacin | 1.0 | S | S | S | S | S |
Kanamycin | 5.0 | S | S | S | S | S |
Capreomycin | 2.5 | S | S | S | S | S |
R, resistant; S, sensitive.